Literature DB >> 22236193

Prognostic significance of SOX2 expression in nasopharyngeal carcinoma.

Xin Wang1, Yi Liang, Qiong Chen, Hui-Min Xu, Nan Ge, Rong-Zhen Luo, Jian-Yong Shao, Zhiwei He, Yi-Xin Zeng, Tiebang Kang, Jing-Ping Yun, Fangyun Xie.   

Abstract

The significance of SOX2 in nasopharyngeal carcinoma (NPC), a tumor associated with Epstein-Barr virus (EBV), remains unclear. Here, we reported that, in the univariate analysis, SOX2 expression was correlated with a poorer distant metastasis-free survival (DMFS). The EBV-VCA/IgA titers in patients with NPC were also associated with a poorer overall survival (OS). Patients with NPC, who had both strong staining of SOX2 and high titers of EBV-VCA/IgA, had the poorest prognoses. Therefore, SOX2 or the combination of the SOX2 expression level and EBV-VCA/IgA titers could be valuable to predict distant metastasis or the prognosis of NPC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236193     DOI: 10.3109/07357907.2011.630049

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  14 in total

1.  Prognostic significance of SOX2 in head and neck cancer: a meta-analysis.

Authors:  Zhongyi Dong; Gengchun Liu; Baqun Huang; Jingyuan Sun; Dehua Wu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.

Authors:  Pilar Bayo; Adriana Jou; Albrecht Stenzinger; Chunxuan Shao; Madeleine Gross; Alexandra Jensen; Niels Grabe; Christel Herold Mende; Pantelis Varvaki Rados; Juergen Debus; Wilko Weichert; Peter K Plinkert; Peter Lichter; Kolja Freier; Jochen Hess
Journal:  Mol Oncol       Date:  2015-05-20       Impact factor: 6.603

3.  High SOX2 levels predict better outcome in non-small cell lung carcinomas.

Authors:  Vamsidhar Velcheti; Kurt Schalper; Xiaopan Yao; Huan Cheng; Mehmet Kocoglu; Kavita Dhodapkar; Yanhong Deng; Scott Gettinger; David L Rimm
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.

Authors:  King Chi Chan; Lai Sheung Chan; Joseph Chok Yan Ip; Carman Lo; Timothy Tak Chun Yip; Roger Kai Cheong Ngan; Ricky Ngok Shun Wong; Kwok Wai Lo; Wai Tong Ng; Anne Wing Mui Lee; George Sai Wah Tsao; Michael Kahn; Maria Li Lung; Nai Ki Mak
Journal:  Sci Rep       Date:  2015-04-21       Impact factor: 4.379

5.  Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.

Authors:  Karen Jung; Peng Wang; Nidhi Gupta; Keshav Gopal; Fang Wu; Xiaoxia Ye; Abdulraheem Alshareef; Gilbert Bigras; Todd P McMullen; Bassam S Abdulkarim; Raymond Lai
Journal:  Breast Cancer Res       Date:  2014-11-08       Impact factor: 6.466

6.  Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporter.

Authors:  Keshav Gopal; Nidhi Gupta; Haifeng Zhang; Abdulraheem Alshareef; Hind Alqahtani; Gilbert Bigras; Jamie Lewis; Donna Douglas; Norman Kneteman; Afsaneh Lavasanifar; Raymond Lai
Journal:  Oncotarget       Date:  2016-01-19

7.  Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.

Authors:  Johanna Samulin Erdem; Vidar Skaug; Per Bakke; Amund Gulsvik; Aage Haugen; Shanbeh Zienolddiny
Journal:  BMC Cancer       Date:  2016-01-19       Impact factor: 4.430

Review 8.  The dark side of SOX2: cancer - a comprehensive overview.

Authors:  Erin L Wuebben; Angie Rizzino
Journal:  Oncotarget       Date:  2017-07-04

9.  YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.

Authors:  Karen Jung; Fang Wu; Peng Wang; Xiaoxia Ye; Bassam S Abdulkarim; Raymond Lai
Journal:  BMC Cancer       Date:  2014-05-09       Impact factor: 4.430

10.  SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.

Authors:  Erin L Wuebben; Phillip J Wilder; Jesse L Cox; James A Grunkemeyer; Thomas Caffrey; Michael A Hollingsworth; Angie Rizzino
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.